Keynote: qPCR Application in Cell and Gene Therapies

Wednesday, October 19, 2022

1:30 PM – 2:30 PM ET

Location:253 B

Moderator(s)

William Hallet, PhD (he/him/his)

Associate Scientific Director
Janssen R&D / J&J
Spring House, Pennsylvania

Keynote Speaker(s)

Kate Herr, M.S.

Scientist
Janssen R&D/ Johnson & Johnson
Norristown, Pennsylvania

Handouts

Overview of cell and gene therapy and how and where qPCR is used in analysis. Important considerations, lack of guidances and a case study are included. Important take home is that context of use should be considered and applied when utilizing qPCR in clinical, non-clinical and biomarker development and analysis.

Learning Objectives:

Gain an understanding of modalities including in cell and gene therapy
Demonstrate how PCR is used as an assay platform for cell and gene therapy.
Highlight important aspects to consider and challenges to overcome.
Explore the different parameters that are involved in PCR development and validation